Our study showed that antibiotic treatment for 12 weeks led to significant changes in the gut microbiota and osteoporosis in mice, and the levels of Ang II and RANKL in serum were significantly increased, suggesting that RAS may play an important role in bone loss due to gut microbiota dysbiosis. This evidence concerns the gene TNFSF11 and osteoporosis.